drugset / Trial / NCT00003556

Vaccine Therapy in Treating Patients With Melanoma

NCT00003556

Phase 1 Completed 15 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of vaccine therapy in treating patients with melanoma that cannot be treated with surgery. Vaccines may make the body build an immune response that may kill tumor cells. Combining more than one vaccine may kill more tumor cells.

Timeline

Start
1999-01
Primary completion
2001-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject ALVAC-hB7.1 Unknown Other
Subject ALVAC-hIL-12 Vaccine Other

Indications